Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
NCT04380610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-09-18
Summary
The investigators will attempt to develop a more accurate equation to estimate eGFR in pediatric and adult sickle cell patients
Conditions
- Sickle Cell Disease
- Renal Disease
- Glomerular Disease
Interventions
- DIAGNOSTIC_TEST
-
iohexol GFR
We will perform mGFR in 400 SCA patients
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
University of Alabama at Birmingham
lead OTHER
Principal Investigators
-
Jeffrey Lebensburger, DO, MSPH · University of Alabama at Birmingham
Eligibility
- Min Age
- 5 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-12
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United States
Study Locations
More Related Trials
-
Sickle Cell Uric Acid (SCUA) - Cohort Repository
NCT04190888 ·Status: COMPLETED
-
The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease
NCT06158945 ·Status: RECRUITING
-
Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia
NCT00001197 ·Status: COMPLETED ·Phase: PHASE2
-
Sickle Cell Clinical Research and Intervention Program
NCT02098863 ·Status: RECRUITING
-
Kidney Function in Sickle Cell Anemia
NCT03277547 ·Status: ACTIVE_NOT_RECRUITING
-
Nephropathy in Patients With Sickle Cell Disease
NCT03680547 ·Status: UNKNOWN
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED
-
Microvessels and Heart Problems in Sickle Cell Disease
NCT01602809 ·Status: COMPLETED
-
"Association of Proteinuria and Progression of Kidney Dysfunction in Sickle Cell Disease"Disease
NCT05407740 ·Status: COMPLETED
-
A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
NCT06286046 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005277 ·Status: COMPLETED
-
Losartan for Sickle Cell Kidney Disease
NCT01989078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Sickle Cell Kidney Biorepository
NCT07064174 ·Status: RECRUITING
-
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
NCT03288012 ·Status: UNKNOWN
-
Screening for Renal Complications in Children and Young Adults With Major Sickle Cell Disease
NCT05211037 ·Status: COMPLETED ·Phase: NA
-
Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
NCT03405688 ·Status: COMPLETED ·Phase: NA
-
Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines
NCT03037021 ·Status: COMPLETED
-
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
NCT03685721 ·Status: RECRUITING
-
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
NCT03401112 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell Anemia
NCT00056433 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
NCT02225132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
NCT03478917 ·Status: COMPLETED
-
Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
NCT01895361 ·Status: COMPLETED ·Phase: PHASE2
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Microvascular and Cardiac Dysfunction in Paroxysmal Nocturnal Hemoglobinuria and Sickle Cell Disease
NCT01294891 ·Status: COMPLETED